Michael Jarman

8.7k citations

225 papers · 7.0k · h-index 46

Impact in

Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
Genetics top 1%
- Estrogen and related hormone effects

Papers in

Molecular Biology 86
- DNA and Nucleic Acid Chemistry 14
Genetics 63
- Estrogen and related hormone effects 61

Co-authors: A. B. Foster (38 shared papers)Martin Rowlands (28 shared papers)Gerard A. Potter (17 shared papers)S. Elaine Barrie (12 shared papers)Raymond McCague (20 shared papers)Mitch Dowsett (16 shared papers)R. Charles Coombes (15 shared papers)P.D. Lawley (3 shared papers)
Journals: Biochemical Pharmacology (33 papers)Journal of Medicinal Chemistry (23 papers)British Journal of Cancer (9 papers)Carbohydrate Research (7 papers)Journal of Mass Spectrometry (6 papers)
Partner nations: United Kingdom United States Poland

In The Last Decade

Michael Jarman

221 papers receiving 6.5k citations

Peers

Replace Joachim G. Liehr with:

Joachim G. Liehr United States

Kathryn E. Carlson United States

Elwood V. Jensen United States

Michael E. Jung United States

Koichi Shudo Japan

Michaël Kahn United States

P Cerutti Switzerland

Thomas C. Hamilton United States

Werner Schroth Germany

B Ketterer United Kingdom

Michael Jarman relative to Joachim G. Liehr United States Joachim G. Liehr's profile →

Citations per field

00.5×2×3×3.8×

Joachim G. Liehr · 1×

×1.2 929/795

PHARM

×0.6 2k/3k

GENET

×0.7 901/1k

CR

×0.5 178/352

TOXIC

×3.8 314/83

PS

Citations per year

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

'26

Countries citing papers authored by Michael Jarman

Since Specialization

Citations

This map shows the geographic impact of Michael Jarman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Jarman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Jarman more than expected).

Fields of papers citing papers by Michael Jarman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Jarman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Jarman. The network helps show where Michael Jarman may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Jarman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Jarman Line = papers co-authored together Michael Jarman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 225 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer British Journal of Cancer ·Anne O’Donnell, Ian Judson, Mitch Dowsett, Florence I. Raynaud, David P. Dearnaley, M. Mason, S.J. Harland, Alissa K. Robbins, Gavin Halbert, Bernard Nutley, Michael Jarman	2004	300
2	Novel Steroidal Inhibitors of Human Cytochrome P45017.alpha.-Hydroxylase-C17,20-lyase): Potential Agents for the Treatment of Prostatic Cancer Journal of Medicinal Chemistry ·Gerard A. Potter, S. Elaine Barrie, Michael Jarman, Martin Rowlands	1995	293
3	Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide Biochemical Pharmacology ·T.A. Connors, Peter J. Cox, Peter B. Farmer, A. B. Foster, Michael Jarman	1974	275
4	Synthetic Procedures in Nucleic Acid Chemistry Carbohydrate Research ·Michael Jarman	1969	215
5	Pharmacology of novel steroidal inhibitors of cytochrome P45017 (17α-hydroxylase/C17–20 lyase) The Journal of Steroid Biochemistry and Molecular Biology ·S. Elaine Barrie, Gerard A. Potter, Phyllis M. Goddard, Benjamin P. Haynes, Mitch Dowsett, Michael Jarman	1994	206
6	Phase I and pharmacokinetic study of d -limonene in patients with advanced cancer Cancer Chemotherapy and Pharmacology ·David M. Vigushin, Grace K. Poon, Alan V. Boddy, Jacqueline English, Gavin Halbert, Christos Pagonis, Michael Jarman, R. Charles Coombes	1998	170
7	Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity Molecular Cancer Therapeutics ·Lindsay Stimson, Martin Rowlands, Yvette Newbatt, Nicola F. Smith, Florence I. Raynaud, Paul A. Rogers, Vassilios Bavetsias, Stephen Gorsuch, Michael Jarman, Andrew J. Bannister, Tony Kouzarides, Edward McDonald, Paul Workman, G. Wynne Aherne	2005	168
8	A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in walker carcinoma cells Biochemical Pharmacology ·Richard J. Knox, Frank Friedlos, Michael Jarman, J. J. Roberts	1988	127
9	The 16,17-Double Bond Is Needed for Irreversible Inhibition of Human Cytochrome P450₁₇_α by Abiraterone (17-(3-Pyridyl)androsta-5,16-dien-3β-ol) and Related Steroidal Inhibitors Journal of Medicinal Chemistry ·Michael Jarman, S. Elaine Barrie, J. M. LLERA	1998	126
10	PREVENTION OF ISOPHOSPHAMIDE-INDUCED UROTHELIAL TOXICITY WITH 2-MERCAPTOETHANE SULPHONATE SODIUM (MESNUM) IN PATIENTS WITH ADVANCED CARCINOMA The Lancet ·B.M. Bryant, H.T. Ford, Michael Jarman, I. E. Smith	1980	112
11	The Synthesis of oligoribonucleotides—IV Tetrahedron ·Beverly E. Griffin, Michael Jarman, Colin B. Reese	1968	105
12	Some Observations Relating to Acyl Mobility in Aminoacyl Soluble Ribonucleic Acids^* Biochemistry ·Beverly E. Griffin, Michael Jarman, Colin B. Reese, John Sulston, David R. Trentham	1966	101
13	Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2 Journal of Medicinal Chemistry ·Caroline J. Springer, Pari Antoniw, Bagshawe, F Searle, Graham M. F. Bisset, Michael Jarman	1990	100
14	Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan British Journal of Cancer ·T J McElwain, David W. Hedley, G. Burton, H.M. Clink, M. Y. Gordon, Michael Jarman, CA Juttner, Jeremy Millar, R. Milsted, G Prentice, Ian E. Smith, David J. Spence, Michael S. Woods	1979	99
15	The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth Cancer Chemotherapy and Pharmacology ·C. Kent Osborne, Michael Jarman, R. MCCAGUE, Ester B. Coronado, Susan G. Hilsenbeck, Alan E. Wakeling	1994	98
16	A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism Carcinogenesis ·Gerard A. Potter, Raymond McCague, Michael Jarman	1994	91
17	Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituent Journal of Medicinal Chemistry ·Raymond McCague, Guy Leclercq, Nicole Legros, Joyce Goodman, G. Michael Blackburn, Michael Jarman, A. B. Foster	1989	90
18	Reaction products from N-methyl-N-nitrosourea and deoxyribonucleic acid containing thymidine residues. Synthesis and identification of a new methylation product, O4-methyl-thymidine Biochemical Journal ·P.D. Lawley, D.J. Orr, S. A. Shah, P. B. Farmer, Michael Jarman	1973	88
19	Isolation and identification of products from alkylation of nucleic acids: ethyl- and isopropyl-purines Biochemical Journal ·P.D. Lawley, D.J. Orr, Michael Jarman	1975	88
20	Hydroxy derivatives of tamoxifen Journal of Medicinal Chemistry ·A. B. Foster, Michael Jarman, On Tai Leung, Raymond McCague, Guy Leclercq, N. Devleeschouwer	1985	83

About Michael Jarman

Michael Jarman is a scholar working on Molecular Biology, Genetics, Organic Chemistry, Oncology and Pharmacology, having authored 225 papers that have together received 7.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (61 papers), Pharmacogenetics and Drug Metabolism (32 papers), Chemical Reactions and Isotopes (22 papers), DNA and Nucleic Acid Chemistry (14 papers), Cancer Treatment and Pharmacology (13 papers), Drug Transport and Resistance Mechanisms (12 papers), Analytical Chemistry and Chromatography (12 papers) and Hormonal and reproductive studies (12 papers). The work is most often cited by research in Pharmacology (929 citations), Genetics (1.8k citations), Cancer Research (901 citations), Toxicology (178 citations) and Pharmaceutical Science (314 citations). Michael Jarman has collaborated with scholars based in United Kingdom, United States and Poland. Frequent co-authors include A. B. Foster, Martin Rowlands, Gerard A. Potter, S. Elaine Barrie, Raymond McCague, Mitch Dowsett, R. Charles Coombes, P.D. Lawley, Peter B. Farmer and Colin B. Reese. Their work appears in journals such as Biochemical Pharmacology, Journal of Medicinal Chemistry, British Journal of Cancer, Carbohydrate Research and Journal of Mass Spectrometry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Michael Jarman

Impact in

Papers in i

In The Last Decade

Michael Jarman

Peers

Countries citing papers authored by Michael Jarman

Fields of papers citing papers by Michael Jarman

All Works

About Michael Jarman

Explore authors with similar magnitude of impact

Papers in